ロード中...
Physician Response to Implementation of Genotype-Tailored Antiplatelet Therapy
Physician responses to genomic information are vital to the success of precision medicine initiatives. We prospectively studied a pharmacogenomics implementation program for the propensity of clinicians to select antiplatelet therapy based on CYP2C19 loss-of-function (LOF) variants in stented patien...
保存先:
| 出版年: | Clin Pharmacol Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4899238/ https://ncbi.nlm.nih.gov/pubmed/26693963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.331 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|